课题基金 / 基金详情

ERA IB 5 A Synthetic Biology approach for bacterial bioconversion of lignin into renewable chemicals (LIGBIO)

ERA IB 5 A Synthetic Biology approach for bacterial bioconversion of lignin into renewable chemicals (LIGBIO)
ERA IB 5 将木质素细菌生物转化为可再生化学品的合成生物学方法 (LIGBIO)
批准号:
BB/M025772/1
负责人:
Timothy Bugg
金额:
$45.48万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Timothy Bugg的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lignin is a polymer found as 15-30% of plant biomass, and is produced industrially as a low-value by-product of pulp/paper manufacture and biofuel production. It contains phenolic monomer units, hence it represents a possible renewable source of aromatic chemicals that are needed industrially to make plastics, pharmaceuticals and agrochemicals, currently derived from crude oil. As part of the effort to develop a sustainable European bio-based chemical industry, we wish to convert lignin into renewable chemicals, however, due to its highly inert structure, no commercial process has yet been developed for conversion of lignin to renewable chemicals. Recently Prof. Bugg's group at Warwick have discovered two novel bacterial lignin-degrading enzymes, and have shown that the lignin breakdown pathways in Rhodococcus jostii RHA1 can be modified genetically in order to generate vanillin, a chemical used in the food/flavour industry. However, at present the metabolic pathways and regulatory systems for lignin breakdown in bacteria are not well understood. Therefore, in this project we will study Pseudomonas putida KT2440, a lignin-degrading bacterium whose genome has been sequenced and whose aromatic metabolic network is the best known in bacteria, to elucidate the metabolic and regulatory networks for lignin degradation. We will then use this knowledge to reprogramme this bacterium, using high activity lignin-degrading enzymes, to produce two target chemicals that are of interest for the production of renewable bioplastics. With industrial partner Biome Bioplastics, we will then develop a fermentation-based process for the production of renewable aromatic chemicals from lignin.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Resource Recovery from Wastes - Towards a Circular Economy
废物资源回收 - 迈向循环经济
DOI: 10.1039/9781788016353-00113
发表时间: 2019
期刊:
影响因子: --
作者: [Lag-Brotons A]
通讯作者: Lag-Brotons A
DOI: 10.1016/j.bbrc.2016.10.144
发表时间: 2017
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Rahman Rahmanpour;Lloyd King;T. Bugg]
通讯作者: Rahman Rahmanpour;Lloyd King;T. Bugg
Protein engineering of Pseudomonas fluorescens peroxidase Dyp1B for oxidation of phenolic and polymeric lignin substrates.
荧光假单胞菌过氧化物酶 Dyp1B 的蛋白质工程用于氧化酚类和聚合木质素底物。
DOI: 10.1016/j.enzmictec.2019.01.002
发表时间: 2019
期刊: Enzyme and microbial technology
影响因子: 3.4
作者: [Rahman Pour R]
通讯作者: Rahman Pour R
DOI: 10.1016/j.abb.2014.12.022
发表时间: 2015-05-15
期刊: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
影响因子: 3.9
作者: [Rahmanpour, Rahman, Bugg, Timothy D. H.]
通讯作者: Bugg, Timothy D. H.
Sustainable Biocatalytic Approaches to Pyridine and Piperidine Heterocycles
  • 批准号:
    BB/Y005589/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $55.48万
  • 财政年份:
    2024
  • 负责人:
    Timothy Bugg
  • 依托单位:
Microbial conversion of lignin to monomers for bio-based plastics using synthetic biology (MILIMO)
  • 批准号:
    BB/T010622/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $47.06万
  • 财政年份:
    2020
  • 负责人:
    Timothy Bugg
  • 依托单位:
[16-FAPESP-BE] Lignin valorization in cellulosic ethanol plants: biocatalytic conversion via ferulic acid to high value chemicals
  • 批准号:
    BB/P01738X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $265.34万
  • 财政年份:
    2017
  • 负责人:
    Timothy Bugg
  • 依托单位:
Bioplastic polymers based on aromatic dicarboxylic acids derived from lignin
  • 批准号:
    EP/M028550/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $43.6万
  • 财政年份:
    2015
  • 负责人:
    Timothy Bugg
  • 依托单位:
国内基金
海外基金
基于IB-GHPC方法的开孔结构物非线性水动力学特性及机理研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
一项评估胰腺癌新型免疫治疗的Ib/II期平台型临床研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    施思
  • 依托单位:
替雷利珠单抗联合短程放化疗转化治疗食管鳞癌的Ib期临床研究
MHC Ib 限制性 CD8+T 细胞抗肿瘤免疫应答的机制与应用策略